HB 5078

  • Michigan House Bill
  • 2023-2024 Regular Session
  • Introduced in House Oct 03, 2023
  • Passed House Apr 24, 2024
  • Passed Senate Dec 10, 2024
  • Governor

Health: pharmaceuticals; distribution of opioid antagonists by employees and agents of agencies under the administration of opioid antagonists act; provide for. Amends sec. 17744b of 1978 PA 368 (MCL 333.17744b). TIE BAR WITH: HB 5077'23

Votes


No votes to display

Actions


Dec 10, 2024

House

full title agreed to

House

returned from Senate without amendment with full title

Senate

INSERTED FULL TITLE

Senate

PASSED ROLL CALL # 477 YEAS 37 NAYS 0 EXCUSED 1 NOT VOTING 0

House

bill ordered enrolled

Nov 13, 2024

Senate

PLACED ON ORDER OF THIRD READING

Senate

REPORTED BY COMMITTEE OF THE WHOLE FAVORABLY WITHOUT AMENDMENT(S)

Oct 31, 2024

Senate

REFERRED TO COMMITTEE OF THE WHOLE

Senate

REPORTED FAVORABLY WITHOUT AMENDMENT

Apr 30, 2024

Senate

REFERRED TO COMMITTEE ON HEALTH POLICY

Apr 24, 2024

House

transmitted

House

read a third time

House

passed; given immediate effect Roll Call # 40 Yeas 96 Nays 11 Excused 0 Not Voting 1

Apr 18, 2024

House

placed on third reading

House

read a second time

Mar 06, 2024

House

referred to second reading

House

reported with recommendation without amendment

Oct 04, 2023

House

bill electronically reproduced 10/03/2023

Oct 03, 2023

House

read a first time

House

referred to Committee on Health Policy

House

introduced by Representative Carrie Rheingans

Bill Text

Bill Text Versions Format
House Introduced Bill HTML PDF
As Passed by the House HTML PDF
As Passed by the Senate HTML PDF
House Concurred Bill HTML PDF
House Enrolled Bill HTML PDF

Related Documents

Document Format
Revised Summary as Reported from Committee (4/24/2024) PDF
Summary as Introduced (10/26/2023) PDF
SUMMARY OF HOUSE-PASSED BILL IN COMMITTEE (Date Completed: 6-18-24) HTML PDF

Sources

Data on Open States is updated periodically throughout the day from the official website of the Michigan Legislature.

If you notice any inconsistencies with these official sources, feel free to file an issue.